KORSUVA (Vifor Pharma Pty Ltd)
Product name
KORSUVA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
211 (255 working days)
Active ingredients
difelikefalin acetate
Registration type
NCE/NBE
Indication
KORSUVA is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis.